EDUCATIONAL SYMPOSIA

  • S1 : Improving Patient Access to Innovative Cancer Therapies: The Role of Managed Entry Agreements
  • S2 : The Implementation of Sustainable Biosimilar Policies to Increase Access to Biological Medicines in CEE Countries

PLENARY SESSIONS

  • P1 : Aligning Evidence Requirements for Drug Authorization and Coverage –Central and Eastern European (CEE) Countries Insights
  • P2 : Health Data, Health Data, and More Health Data: From Quantity to Quality Through Cooperation
  • P3 : Medical Device Assessment and Procurement - Fair and Efficient Access in Countries with Limited Health Budgets
  • P4 : How Far Can We Go? Finding a Common Way in Clinical Evaluation, Data Generation, and Joint Procurement and Pricing Negotiations